Systemic Lupus Erythematosus: Targeted literature review of the epidemiology, current treatment and disease burden in the Asia Pacific region.
Yoshiya TanakaSean O'NeillMeng Tao LiI-Ching TsaiYa-Wen YangPublished in: Arthritis care & research (2020)
SLE remains a disease with a significant unmet medical need for an innovative therapy that is well-tolerated and effective for patients in APAC. Further evidence is required to better characterize the disease and fully capture the burden and impact of SLE in APAC. This review has highlighted where there is a paucity of data from patients across the APAC region.
Keyphrases
- machine learning
- artificial intelligence
- systemic lupus erythematosus
- end stage renal disease
- ejection fraction
- chronic kidney disease
- disease activity
- peritoneal dialysis
- prognostic factors
- drug delivery
- stem cells
- mesenchymal stem cells
- rheumatoid arthritis
- patient reported outcomes
- electronic health record
- cancer therapy
- case report
- data analysis